JHEP Reports

Scope & Guideline

Advancing healthcare knowledge through open access.

Introduction

Delve into the academic richness of JHEP Reports with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN-
PublisherELSEVIER
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationJHEP REP / JHEP Rep.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS

Aims and Scopes

JHEP Reports is focused on advancing the understanding and treatment of liver diseases. The journal emphasizes the integration of clinical findings with molecular and cellular mechanisms, aiming to bridge the gap between basic research and clinical application. It serves as a platform for innovative research in hepatology, particularly in areas related to liver cancer, hepatitis, liver transplantation, and metabolic liver diseases.
  1. Liver Disease Pathophysiology:
    Investigation into the underlying mechanisms and biological pathways involved in various liver diseases, including viral hepatitis, metabolic dysfunction-associated liver disease, and hepatocellular carcinoma.
  2. Clinical Management and Therapeutics:
    Studies addressing the clinical management of liver diseases, including novel therapeutic approaches, patient management strategies, and the impact of treatments on patient outcomes.
  3. Translational Research:
    Research that translates findings from basic science into clinical practice, focusing on biomarkers, therapeutic targets, and the efficacy of interventions in liver disease.
  4. Epidemiology and Public Health:
    Exploration of the epidemiological trends, risk factors, and public health implications associated with liver diseases, emphasizing the need for effective screening and prevention strategies.
  5. Innovative Diagnostic Techniques:
    Development and validation of new diagnostic tools and biomarkers for the early detection and monitoring of liver diseases, enhancing the precision of clinical assessments.
The landscape of liver disease research is evolving, with several themes emerging as particularly relevant in recent years. These trends reflect the ongoing advancements in understanding liver pathology and the development of innovative treatment strategies.
  1. Immunotherapy for Liver Cancer:
    There is a growing interest in exploring immunotherapeutic approaches for hepatocellular carcinoma, reflecting a broader trend in oncology towards harnessing the immune system to target cancer.
  2. Metabolic Liver Diseases:
    Research on metabolic dysfunction-associated fatty liver disease (MAFLD) is increasingly prominent, reflecting the rising global burden of obesity-related liver conditions and their complexities.
  3. Precision Medicine and Personalized Approaches:
    Emerging studies are increasingly focusing on personalized treatment plans based on genetic, metabolic, and immunological profiles, tailored to improve outcomes in liver disease patients.
  4. Microbiome and Liver Health:
    The exploration of the gut-liver axis and the role of the microbiome in liver disease pathogenesis and treatment is gaining traction, highlighting the interconnectedness of systems in health.
  5. Non-Invasive Biomarkers:
    There is a significant trend towards the development and validation of non-invasive biomarkers for liver disease diagnosis and monitoring, as researchers seek to reduce reliance on invasive procedures.

Declining or Waning

While JHEP Reports continues to publish a wide array of studies, certain themes appear to be losing prominence over recent years. This shift may reflect changing research priorities or advancements in treatment modalities that reduce the relevance of older topics.
  1. Traditional Imaging Techniques:
    There is a noticeable decline in studies focused solely on traditional imaging methods for liver disease diagnosis, as newer, more sophisticated techniques and biomarkers gain traction.
  2. Hepatitis C Management:
    Research specifically centered on hepatitis C management has waned, likely due to the successful implementation of direct-acting antiviral therapies that have transformed treatment approaches.
  3. Liver Disease Epidemiology in Stable Populations:
    There seems to be a decrease in studies that focus on static epidemiological data from stable populations, with a shift towards dynamic, real-time analyses that capture emerging trends and variations.
  4. Basic Science of Non-Alcoholic Fatty Liver Disease (NAFLD):
    Research detailing basic mechanisms of NAFLD appears to be declining as the focus shifts towards more clinically relevant studies that explore treatment outcomes and patient management.
  5. Palliative Care Approaches in Hepatology:
    The emphasis on palliative care strategies in liver disease management is decreasing, possibly as more effective curative and management options become available.

Similar Journals

Hepatology Forum

Fostering collaboration in the fight against liver disorders.
Publisher: KARE PUBLISSN: 1307-5888Frequency: 4 issues/year

Hepatology Forum is an esteemed journal dedicated to disseminating cutting-edge research and insights in the fields of gastroenterology and hepatology. Published by KARE PUBL in Turkey, this journal serves as a vital platform for researchers, clinicians, and healthcare professionals aiming to advance their knowledge and practices related to liver diseases and gastrointestinal disorders. With an ISSN of 1307-5888 and an E-ISSN of 2757-7392, it features peer-reviewed articles that encompass a wide range of topics from basic research to clinical applications. Although categorized in the Q3 quartile for both gastroenterology and hepatology in 2023, Hepatology Forum continues to show significant potential for growth and impact, as evidenced by its Scopus rankings. Through its commitment to open scientific exchange, the journal not only facilitates the sharing of innovative methodologies and findings but also fosters networking among professionals in the field. As it converges through the years from 2020 to 2024, Hepatology Forum remains an important resource for the advancement of liver health and diseases, appealing to both established experts and emerging scholars alike.

Canadian Journal of Gastroenterology and Hepatology

Your Gateway to Cutting-edge Gastroenterology Insights
Publisher: HINDAWI LTDISSN: 2291-2789Frequency: 1 issue/year

Canadian Journal of Gastroenterology and Hepatology, published by HINDAWI LTD, serves as a vital resource in the fields of gastroenterology and hepatology. Since its inception in 1987, this open-access journal has made significant contributions to advancing research and clinical practice through its comprehensive coverage of topics ranging from liver diseases to gastrointestinal disorders. With an impressive Q2 ranking in Gastroenterology and a Q3 ranking in Hepatology as of 2023, the journal has established itself as an influential platform for researchers and healthcare professionals seeking to disseminate and acquire knowledge. The journal is based in Egypt, with its operational headquarters located in London, England. Notably, it holds a respectable standing in Scopus rankings, placed at Rank #64 in Gastroenterology and Rank #34 in Hepatology, reflecting its impact and relevance in the medical community. With a commitment to quality and accessibility, the Canadian Journal of Gastroenterology and Hepatology continues to foster innovation and collaboration among its readers.

Journal of Clinical and Experimental Hepatology

Connecting experts to elevate the field of hepatology.
Publisher: ELSEVIER - DIVISION REED ELSEVIER INDIA PVT LTDISSN: 0973-6883Frequency: 4 issues/year

The Journal of Clinical and Experimental Hepatology, published by Elsevier - Division Reed Elsevier India Pvt Ltd, is a premier platform dedicated to advancing the field of hepatology. With an ISSN of 0973-6883 and an E-ISSN of 2213-3453, this journal has gained recognition for its impactful contributions to both clinical practice and scientific research in the domain of liver health. Ranking in the Q2 quartile for Hepatology in 2023 and positioned at 33rd out of 82 in Scopus’s Hepatology category, it reflects a robust impact factor and a commitment to publishing high-quality, peer-reviewed articles. Researchers, clinicians, and students can engage with a wealth of open-access content covering the latest advancements, challenges, and insights in hepatology, as the journal aims to disseminate knowledge from 2011 through 2025. Join the community of experts as we explore critical developments in the understanding and treatment of liver diseases.

Clinical and Molecular Hepatology

Bridging clinical practice and molecular discoveries in liver health.
Publisher: KOREAN ASSOC STUDY LIVERISSN: 2287-2728Frequency: 4 issues/year

Clinical and Molecular Hepatology, published by the Korean Association for the Study of Liver, stands at the forefront of hepatology, offering a significant platform for research and innovation in liver diseases. Established in 1995 as an open access journal, it aims to disseminate high-quality research that spans the fields of hepatology, molecular biology, and medicine. With an impressive impact factor ranking it in the Q1 category for 2023 in both Hepatology and Molecular Biology, the journal facilitates a rich exchange of knowledge among professionals, researchers, and students globally. With its dedicated coverage from 2012 to 2024 and exceptional Scopus rankings placing it within the top 10% of journals in its field, Clinical and Molecular Hepatology is an indispensable resource for advancing the understanding and treatment of liver conditions. Located in Seoul, South Korea, the journal emphasizes rigorous peer review and is committed to enhancing clinical practice and molecular research, making it an ideal venue for groundbreaking studies in liver health.

Korean Journal of Gastroenterology

Your Gateway to Gastrointestinal Research and Innovation
Publisher: Korean Soc GastroenterologyISSN: 1598-9992Frequency: 12 issues/year

Korean Journal of Gastroenterology (ISSN: 1598-9992, E-ISSN: 2233-6869), published by the Korean Society of Gastroenterology, has been a premier outlet for research and advancements in the field of gastroenterology since its inception in 1968. This open-access journal, based in South Korea, fosters a global dialogue on gastrointestinal health, embracing contributions from a diverse array of disciplines within medicine. It is currently ranked in the Q4 quartile for miscellaneous medicine and holds a Scopus rank of #323 out of 636 in general medicine, reflecting its commitment to publishing impactful research despite its relatively recent establishment in high-impact metrics. With a continuous publication timeline extending through to 2024, the journal aims to enhance understanding of gastrointestinal disorders and promote innovative treatments, making it an essential resource for researchers, clinicians, and students alike who seek to stay abreast of the latest developments and clinical applications in gastroenterology.

World Journal of Hepatology

Leading the way in hepatology research and education.
Publisher: BAISHIDENG PUBLISHING GROUP INCISSN: 1948-5182Frequency: 12 issues/year

World Journal of Hepatology is a premier academic journal dedicated to advancing the field of hepatology. Published by BAISHIDENG PUBLISHING GROUP INC, this journal serves as a crucial platform for disseminating innovative research findings and critical reviews from around the globe. With its ISSN 1948-5182 and E-ISSN 1948-5182, the journal has established a notable presence since its inception in 2009, covering a wide range of topics relevant to liver diseases, including but not limited to hepatitis, liver cancer, and metabolic liver disorders. Currently ranked 41/82 in the field of hepatology by Scopus, representing the 50th percentile, it has achieved a Q3 quartile ranking in the 2023 category, underscoring its growing influence in the medical community. With a commitment to open access for its readership, the World Journal of Hepatology enriches the global discourse on liver health and disease management, making it an essential resource for researchers, clinicians, and students alike.

Hepatitis Monthly

Illuminating the path to innovative hepatitis solutions.
Publisher: BRIEFLANDISSN: 1735-143XFrequency: 12 issues/year

Hepatitis Monthly, published by BRIEFLAND in the Netherlands, is a pivotal journal in the fields of hepatology and infectious diseases. Established in 2007, it continues to make significant contributions to the understanding and management of hepatitis and related viral infections with a publication timeline extending through to 2024. Aiming to disseminate high-quality research, the journal serves as a forum for groundbreaking studies and innovations essential for healthcare professionals, researchers, and students alike. While it currently holds Q4 rankings in both hepatology and infectious disease categories, its ongoing commitment to addressing pressing health issues makes it an important resource in the academic community. Although it operates under a traditional access model, Hepatitis Monthly not only publishes original research articles, reviews, and case studies but also encourages the exchange of knowledge that helps shape future research directions and clinical practices. As it continues to explore the complexities surrounding viral hepatitis, this journal invites researchers to contribute to its mission of advancing scientific understanding and improving patient care.

JGH Open

Connecting Researchers, Transforming Outcomes
Publisher: WILEYISSN: 2397-9070Frequency: 1 issue/year

JGH Open is a prominent open-access journal dedicated to advancing knowledge in the fields of Gastroenterology and Hepatology, published by WILEY. Since its inception in 2017, the journal has served as a crucial platform for researchers, professionals, and students to disseminate innovative research findings and clinical insights. With an impact factor and Scopus rankings reflecting its steady growth—ranking in the 3rd quartile for both Gastroenterology (Q3) and Hepatology (Q3)—JGH Open is positioned within the competitive landscape of medicine. Its commitment to open access enhances the visibility and accessibility of high-quality research, ensuring that significant advancements in understanding diseases of the gastrointestinal tract and liver reach a broad audience. With a focus on collaboration and dissemination of knowledge, JGH Open aims to contribute to the global discourse and improve outcomes in gastrointestinal health.

JOURNAL OF HEPATOLOGY

Exploring Breakthroughs in Liver Disease Management
Publisher: ELSEVIERISSN: 0168-8278Frequency: 12 issues/year

JOURNAL OF HEPATOLOGY, published by Elsevier, stands as a preeminent source in the field of Hepatology, with its impact underscored by a remarkable 2023 Category Quartile of Q1 and a Scopus rank of 3rd out of 82 journals, placing it in the 96th percentile for the discipline. Since its inception in 1985, this journal has been a vital conduit for the dissemination of pioneering research, clinical studies, and reviews related to liver diseases and their impact on global health. Although it currently does not offer open access options, the journal is committed to providing top-tier content to its readership—researchers, medical professionals, and students—in order to advance knowledge and foster innovation in hepatology. With a broad and inclusive scope, it aims to cover significant breakthroughs, therapeutic advancements, and epidemiological studies, continually pushing the boundaries of understanding in liver health. The journal is based in Amsterdam, Netherlands, and remains an essential resource for those dedicated to the progression of hepatologic science.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Uncovering the latest in digestive health advancements.
Publisher: WILEYISSN: 0815-9319Frequency: 12 issues/year

Welcome to the JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, an esteemed publication in the field of gastroenterology and hepatology, proudly published by WILEY. Established in 1986, this journal serves as a crucial platform for researchers, healthcare professionals, and students, presenting groundbreaking research and comprehensive reviews that drive advances in understanding and treating gastrointestinal and liver diseases. With a strong reputation evidenced by its Q1 ranking in gastroenterology and Q2 ranking in hepatology, this journal ranks impressively in the Scopus metrics - positioned at #22 out of 167 in gastroenterology and #21 out of 82 in hepatology, reflecting its contribution to scholarly excellence. Although it does not offer open access options, the journal’s rich archive and diverse topics make it indispensable for those dedicated to improving patient outcomes in these critical areas of medicine. Whether you are a seasoned researcher or an aspiring medical professional, engaging with this journal will keep you at the forefront of the latest developments and emerging trends in gastroenterology and hepatology research.